Delta Capital Partners Management LLC, Chicago-Based Litigation Finance Firm, Announces New Offices and Hires

CHICAGO, Jan. 8, 2020 –Delta Capital Partners Management LLC, a private equity and advisory firm specializing in litigation finance, today announced major milestones in its growth.

Christopher DeLise, Delta’s Managing Principal, CEO and CO-CIO, stated, “Delta has met its key business objectives for 2019 by hiring top-tier professionals, building out our geographic footprint, and joining forces with a top-tier global financial partner.  These developments have strengthened Delta’s AUM and the successful completion of recoveries for claimants, Delta and the firm’s investors. We look forward to continuing to provide world-class services to our investors and clients in 2020.”

Delta’s Geographic Reach and Team Expansion

In 2019, Delta increased its presence in several geographies where it had historically done business, by opening offices in Madrid, Prague, Warsaw and Hong Kong.

New Management Team Members 

Daniel Bond, Esq., Managing Director

Daniel Bond has been hired to lead Delta’s intake, evaluation, due diligence, and monitoring efforts to support new investment opportunities. Mr. Bond was previously a Partner at Kirkland Ellis LLP. Mr. Bond has had a 10+ year law firm career with extensive experience in the planning and management of commercial litigation and dispute resolution.

Since 2015, Mr. Bond has been named by Leading Lawyers as an “Emerging Lawyer in Illinois,” an honor given to the top 2% of lawyers who are 40 years old or younger or practicing law 10 years or less, who have proven themselves professional, ethical and experienced at an early point in their legal career.

Michael Makridakis, Esq., Managing Director – Asia, Australia and Offshore Jurisdictions

Michael Makridakis has been hired to lead Delta’s business in Asia, Australia, and in the Offshore Jurisdictions including the Cayman Islands, BVI and the Channel Islands. Mr. Makridakis works out of the firm’s Hong Kong office.

Prior to joining Delta, Mr. Makridakis was Managing Partner and Head of Dispute Resolution & Insolvency of the Hong-Kong office of Carey Olsen. Mr. Makridakis has a broad range of experience with investment funds, both offshore and domestically. Mr. Makridakis has worked extensively with distressed investment funds and has been a commercial litigator for over 15 years with extensive global litigation and arbitration expertise. Prior to launching the Hong-Kong office of Carey Olsen, Mr. Makridakis practiced law in the Cayman Islands, starting his career with Walkers Global in 2008.

Petr Malecek, Esq., Managing Director – Central & Eastern Europe

Petr Malecek has been hired to lead Delta’s business in Central and Eastern Europe. Mr. Malecek works out of the firm’s Warsaw and Prague offices. Mr. Malecek has over 20 years of experience advising corporate and sovereign entities on banking, finance and dispute-related matters in jurisdictions across Central and Eastern Europe and the Middle East.

Prior to joining Delta, Mr. Malecek co-founded a multi-disciplinary advisory practice where his areas of expertise included litigation management, dispute resolution, asset recovery, cross-border leveraged finance and the coordination of the company’s  advisors/practices and external contractors. Previously, Mr. Malecek was a Partner at CMS Cameron Mckenna and ran the banking and finance practices in Warsaw and Kyiv during that time.

Joseph Drozd, Jr., Director – Strategic Initiatives & Investor Relations

Joseph Drozd brings over ten years of experience in investment management and specializes in fundraising and managing a fund’s entire investment process. Before joining Delta, Mr. Drozd was the director of strategy and marketing with a major Chicago-based investment management company.    Joe formerly was a portfolio manager and director of research for a multi-family office in Chicago and previously worked in the alternatives group at Mercer Investments.

Jennifer Conley, Director – Marketing & Communications

Jennifer Conley has been hired to lead Delta’s marketing and communications efforts. Ms. Conley has worked in marketing and business development across the legal and financial services industries for over 13 years. Ms. Conley is responsible for developing marketing and branding strategies, client pitches and proposals, social media initiatives, competitive intelligence research, national conference sponsorships, and client socials.  Prior to joining Delta, Ms. Conley was a Global Practice Development Manager at Winston & Strawn and focused on practice and client development initiatives for the firm.

In addition to the new management team members noted above, Delta also hired several support, finance, accounting, and legal professionals during 2019, including: Daniel Noonan, Alon Polischuk, and Erin Bishop, Esq.

Delta’s Institutional Financial Partner in 2019

In May 2019, Delta entered a joint venture with a prominent Chicago-based asset manager that has made more than 60 investments since 2007.  The firm has had commitments and deployments of over $5 billion since inception and has an AUM of $9 billion.  The firm manages funds with a variety of investment strategies, including private equity, venture capital, specialty financing, distressed bond and credit alternatives, and has invested extensively in litigation finance over the last decade.

About Delta Capital Partners Management LLC

Delta Capital Partners Management LLC is a US-based private equity and advisory firm specializing in litigation finance, judgment enforcement, asset recovery and related strategies serving claimants, law firms and other professional service firms, and businesses across the globe. The firm provides capital and expertise that enables their clients to de-risk, focus on their core businesses, and significantly enhance the probability of a successful and timely resolution of their and/or their clients’ claims.

Contact:

Delta Capital Partners

Jennifer Conley, 312-481-8194

jconley@deltacph.com

Announcements

View All

Legal Bay Presettlement Funding Reports Updates to Zantac Lawsuits

By Harry Moran |

Legal-Bay LLC, a leading pre settlement funding company, reports that November's $2.2 billion ruling against GlaxoSmithKline has still not been distributed to 80,000+ Zantac plaintiffs. The UK-based pharmaceutical company has been the target of numerous lawsuits for the past five years with plaintiffs alleging the popular heartburn medication causes cancer, and that the company failed to warn users that its main ingredient—ranitidine—may be a human carcinogen.

Testing last month determined how such dangerous levels of ranitidine ended up in the antacid product. As it turns out, impurities in the NDMA found in ranitidine increase when exposed to higher temps and humid conditions. Meaning that the Zantac may have been manufactured correctly, but when it was stored in a damp bathroom or glove compartment of a car, users themselves may have unwittingly triggered the very agent that caused their cancer. 

Chris Janish, CEO of Legal Bay, says, "GSK felt it was in the company's best interest to settle the lawsuits in order to appease shareholders rather than draw out litigation endlessly, especially considering they have been able to do so while providing no admission of liability. While we don't have an exact timeline for when payouts are expected to begin, we are nonetheless offering funding for Zantac plaintiffs while they wait."

To apply for a cash advance lawsuit loan from your anticipated GSK Zantac lawsuit settlement, please visit the company's website HERE or call 877.571.0405.   

There is no way to estimate final settlement amounts or how much each plaintiff's case will be worth. Similar case values have been determined based on extent/amount of injuries along with the level of merit to the case. Each case is unique, and many factors go into deciding final damages. For the Zantac lawsuit payouts, plaintiffs will fall into one of three tiers:

  • Tier I:

Tier 1 injuries can expect payouts in the $300,000 range.  Injuries in this tier include cancers of the stomach, prostate, pancreas, or breast.

  • Tier II:

Tier 2 injuries can expect payouts between $80,000 and 160,000 in most cases.  Injuries in this tier include cancers of the major organs like bladder, kidney, or liver.

  • Tier III:

Tier 3 injuries are looking at payouts anywhere between $20,000 and $60,000.  Injuries in this tier vary greatly, but to a lesser extent than Tier I or II.

The verdicts in these lawsuits are wildly inconsistent and entirely unpredictable, and Legal Bay says there are no guarantees of award amounts nor time frames for payouts just based on the sheer number of claims to process. Nevertheless, Legal-Bay is one of the few legal funding companies who are providing some financial relief to Zantac lawsuit plaintiffs and their families with risk-free, non-recourse cash advance settlement loans. They have been a leader in the mass tort and Qui Tam arena for over fifteen years and have vast experience within this space. These litigations are complex, and Legal Bay has the knowledge and understanding to help plaintiffs navigate the complicated waters of the legal system.

If you're a plaintiff in an active GSK Zantac lawsuit and need an immediate cash advance from your anticipated settlement, please visit the company's website HERE or call 877.571.0405 where agents are standing by to hear about your specific case. 

Legal-Bay is one of the best lawsuit loan companies when it comes to mass tort and Qui Tam litigations, and has a great reputation within the industry. Legal-Bay assists plaintiffs in all types of class action and mass tort lawsuits, including: Round Up, Hernia Mesh, IVC Filters, Essure, Exactech hip and knee recall, Sex Abuse cases, JUUL, and more.

Legal-Bay assists plaintiffs in all other types of lawsuits including personal injury, dog bites, motor vehicle accidents, medical malpractice, police brutality, unlawful incarceration, workplace discrimination, wrongful termination, and more.

Legal-Bay's loan for settlement funding programs are designed to provide immediate cash in advance of a plaintiff's anticipated monetary award. While it's common to refer to these legal funding requests as settlement loans, loans for settlements, law suit loans, loans for lawsuits, etc., the "lawsuit loan" funds are, in fact, non-recourse. That means there's no risk when it comes to loans in lawsuit settlements because there is no obligation to repay the money if the recipient loses their case. Therefore, terms like settlement loan, loans for lawsuit, loans on settlement, or lawsuit loan funds don't necessarily apply, as the "loan on lawsuit" isn't really a loan at all, but rather a stress-free cash advance.

Legal-Bay is known to many as the best lawsuit funding provider in the industry for their helpful and knowledgeable staff, low rates, and quick turnaround, sometimes within 24-48 hours once all documents have been received.

To apply right now for a loan settlement program, please visit the company's website HERE or call toll-free at: 877.571.0405 where agents are standing by to answer any questions.

Latest Burford Quarterly Explores Key Trends Driving Innovation in Commercial Disputes in 2025

By Harry Moran |

Burford Capital, the leading global finance and asset management firm focused on law, today releases its latest Burford Quarterly, a journal of legal finance that explores top trends at the nexus of law and finance.

This Burford Quarterly examines the innovative ways in which businesses and law firms are reimagining their financial strategies around commercial disputes. Examples of this include law firms using creative billing structures as alternatives to hourly fees; companies choosing to opt out of litigation to maximize and accelerate recoveries; or businesses monetizing IP assets, allowing for continued investment in other vital areas of the business.

Articles in the Burford Quarterly No.1 2025 include:

  • The innovation engine: Legal finance for forward-thinking law firms

As law firms launch into 2025, a year that promises continued disruption and opportunity, innovation is not a choice—it's an imperative. Forward-thinking firms are reimagining their financial strategies, moving beyond traditional models to embrace legal finance as a critical tool for transformation. In this article, Travis Lenkner and Emily Slater explore innovative ways legal finance is helping firms solve pressing challenges and accelerate growth. 

  • Healthcare antitrust opt-outs: Improving liquidity by monetizing valuable legal claims

An increasing number of healthcare businesses are recognizing the value that legal finance provides in helping to mitigate the financial strain of high-cost litigation and expedite recoveries in high-stakes litigation. Ahead of a March 2025 opt-out deadline for claimants in the Blue Cross Blue Shield (BCBS) antitrust class actions, Charles Griffin summarizes insights from a recent webcast in which experts from Burford and Paul Hastings presented factors hospital networks and providers should consider in weighing their options.

  • Legal finance and life sciences: Unlocking IP potential in pharma, biotech and medical devices

Innovation in Europe's life sciences and pharmaceutical sectors is vital, but long R&D cycles and short profit windows pose challenges. Joshua Harris explains how legal finance helps companies protect and monetize IP assets, enabling continued investment in life-saving technologies.

  • International arbitration in London: Next-Gen leaders' perspective

Geoff Nicholas, Christiane Deniger and James MacKinnon lead a Burford roundtable with London-based arbitration lawyers. Partners from A&O Shearman, Debevoise & Plimpton, Bryan Cave Leighton Paisner and Freshfields share their insights on key trends and challenges shaping international arbitration, including the use of technology and AI and arbitral efficiency.

Aviva Will, President of Burford Capital, says: "While the legal industry may be slow to evolve, legal finance is a powerful tool to drive innovation in the business of law. This issue of the Burford Quarterly highlights key trends in commercial litigation and arbitration in 2025 and shows how litigation funding continues to shape the legal industry. By providing capital and mitigating risk, funding removes barriers for businesses and facilitates growth, and the latest Quarterly brings insights, analysis and real-world examples of tools to help business executives, GCs, CLOs and law firm attorneys recognize and harness the full potential of finance for law."

About Burford Capital

Burford Capital is the leading global finance and asset management firm focused on law. Its businesses include litigation finance and risk management, asset recovery and a wide range of legal finance and advisory activities. Burford is publicly traded on the New York Stock Exchange (NYSE: BUR) and the London Stock Exchange (LSE: BUR), and it works with companies and law firms around the world from its offices in New York, London, Chicago, Washington, DC, Singapore, Dubai and Hong Kong.

For more information, please visit www.burfordcapital.com.

This announcement does not constitute an offer to sell or the solicitation of an offer to buy any ordinary shares or other securities of Burford.

Rockpoint Legal Funding Highlights TrialBase’s Deposition Services as a Game-Changer for Legal Professionals

By Harry Moran |

Rockpoint Legal Funding is excited to introduce their integration with TrialBase (TrialBase.com), a leader in certified deposition services and legal reporting solutions, as a valuable resource for legal professionals. Attorneys can now instantly apply for litigation funding from Rockpoint directly within Trialbase in order to cover deposition costs on their cases.

TrialBase's cutting-edge deposition management services are uniquely positioned to enhance the efficiency of legal teams, while Rockpoint Legal Funding continues to provide trusted non-recourse funding solutions that empower attorneys to focus on winning cases.

Why TrialBase is an Ideal Resource for Legal Professionals:

Legal professionals often face complex challenges, from managing intricate discovery processes to ensuring financial stability for their clients. Together, TrialBase and Rockpoint Legal Funding can address these issues through:

1.    Streamlined Deposition Services:

TrialBase offers certified deposition management solutions through an integrated platform, helping legal teams save time and enhance case preparation.

2.    Financial Stability for Clients:

Attorneys can use Rockpoint's litigation funding to cover deposition costs and to reduce financial stress - allowing attorneys to focus on their case strategies without unnecessary delays.

3.    Secure Digital Workflow:

Both companies leverage secure, user-friendly platforms, enabling seamless, efficient support for legal professionals.